ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2006 • ACR Convergence 2023

    Improvement of Care: Osteoporosis Screening in a Resident-led Primary Care Clinic

    Massiel Jimenez Artiles1, Roshan Subedi2, Qi Wang3, Bishara Jahshan4, Khalid Gadir4 and Waleed Quwatli5, 1Unity Hospital, Rochester Regional Health, Greece, NY, 2Rochester Regional Health/Unity Hospital, Greece, NY, 3Rochester Regional Health/Unity Hospital, Rochester, NY, 4Unity Hospital, Rochester Regional Health, Rochester, NY, 5Unity Hospital/ Rochester Regional Health, Rochester, NM

    Background/Purpose: Osteoporotic fractures, especially hip fractures, are associated with significant morbidity, including limitations in ambulation, disability, and decreased quality of life. The aim of this…
  • Abstract Number: 2008 • ACR Convergence 2023

    Comparative Effectiveness of Denosumab versus Alendronate Among Postmenopausal Women with Osteoporosis in the U.S. Medicare Program

    Jeffrey Curtis1, Tarun Arora2, Ye Liu1, Tzu-Chieh Lin3, Leslie Spangler3, Vanessa C. Brunetti3, Robert K. Stad3, Michele McDermott3, Brian D. Bradbury3 and Min Kim3, 1University of Alabama at Birmingham, Birmingham, AL, 2Foundation for Advancing Science, Technology, Education, and Research, Birmingham, AL, 3Amgen, Inc., Thousand Oaks, CA

    Background/Purpose: Although clinical trials have shown that denosumab (Dmab) significantly increases bone mineral density at key skeletal sites more than oral bisphosphonates, evidence is lacking…
  • Abstract Number: 2009 • ACR Convergence 2023

    Screening and Treatment of Low Bone Mineral Density in Allogeneic Hematopoietic Cell Transplant Patients

    Perry Fuchs, Christina Ferraro, Chao Zhang, Chad Deal, Betty Hamilton and Sarah Keller, Cleveland Clinic Foundation, Cleveland, OH

    Background/Purpose: Bone mineral density (BMD) loss and fracture are important causes of increased morbidity following allogeneic hematopoietic stem cell transplant (allo-HCT).Recent societal recommendations support screeningDual…
  • Abstract Number: 1957 • ACR Convergence 2023

    Non-Linear Mendelian Randomization Analyses Support a Role for Low Vitamin D Status in Sarcopenia Risk

    Tingting Sha1, Yilun Wang2, Yuqing Zhang3, Nancy Lane4, Changjun Li5, Jie Wei6, Chao Zeng2 and Guanghua Lei2, 1Hunan Key Laboratory of Joint Degeneration and Injury, Changsha, China, 2Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China, 3Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 4University of California, Hillsborough, CA, 5National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China, 6Health Management Center, Xiangya Hospital Central South University, Changsha, China

    Background/Purpose: Vitamin D deficiency is commonly associated with sarcopenia; however, the latest International Clinical Practice Guidelines for Sarcopenia do not recommend vitamin D supplementation for…
  • Abstract Number: 1950 • ACR Convergence 2023

    Thromboembolic Risk Associated with Intravenous Immune Globulin Use in Patients with Idiopathic Inflammatory Myopathy: A Large Database Study

    Rohan Mehta1, Mike Putman2 and Didem Saygin3, 1Medical College of Wisconsin, Milwaukee, WI, 2Division of Rheumatology, Medical College of Wisconsin, Milwaukee, WI, 3University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Intravenous immune globulin (IVIG) recently received regulatory approval for the treatment of dermatomyositis, one of the idiopathic inflammatory myopathies (IIM). The pivotal randomized trial…
  • Abstract Number: 1966 • ACR Convergence 2023

    Investigating Esophageal Involvement in Anti-Synthetase Syndrome: How to Discover the Submerged?

    Federico Fattorini1, Chiara Cardelli1, Simone Barsotti2, Michele Diomedi1, Elenia Laurino1, Mariano Grosso3, Linda Carli1 and Marta Mosca1, 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 2Internal Medicine, Ospedale di Livorno, Pisa, Italy, 3Nuclear Medicine, Department of Translational Research and New Technology in Medicine, University of Pisa, Pisa, Italy

    Background/Purpose: Anti-synthetase syndrome (ASS) is an idiopathic inflammatory myopathy, typically characterized from the triad interstitial lung disease (ILD), myositis and arthritis, together with anti-aminoacyl tRNA…
  • Abstract Number: 1948 • ACR Convergence 2023

    The Influence of Specific Myositis Antibodies on the Development of Interstitial Lung Disease

    Ting-Yuan Lan1, Tai-Ju Lee1, Kuan-Yen Lin2, Jui-Hung Kao3, Chiao-Feng Cheng4, Cheng-Hsun Lu4, Chieh-Yu Shen4, Ko-Jen Li4 and Song-Chou Hsieh4, 1National Taiwan University Hospital Hsinchu Branch, Hsinchu City, Taiwan, 2National Taiwan University Hsinchu branch, Hsinchu, Taiwan, 3National Taiwan University Hospital Yunlin branch, Yunlin, Taiwan, 4National Taiwan University Hospital, Taipei, Taiwan

    Background/Purpose: Interstitial Lung Disease (ILD), prevalent in Idiopathic Inflammatory Myositis (IIM) patients, significantly impacts prognosis. Certain myositis-specific antibodies, including anti-MDA5 and anti-aminoacyl-tRNA synthetases (ARS), are…
  • Abstract Number: 1172 • ACR Convergence 2023

    Relapse Rate After Glucocorticoid-free Remission in Idiopathic Inflammatory Myopathies with Validation of the International Myositis Assessment & Clinical Studies Group (IMACS) Criteria for Remission and Relapse

    Hideaki Tsuji1, Fabricio Espinosa-Ortega2, Maryam Dastmalchi2, Ingrid Lundberg2 and Karin Lodin3, 1Division of Rheumatology, Department of Medicine, Karolinska Institutet; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan, 2Division of Rheumatology, Department of Medicine, Karolinska Institutet; Department of Gastroenterology, Dermatotology, Rhematology, Karolinska Universitetssjukhuset, Stockholm, Sweden, 3Division of Rheumatology, Department of Medicine, Karolinska Institutet; Department of Gastroenterology, Dermatotology, Rhematology, Karolinska Universitetssjukhuset, Huddinge, Sweden

    Background/Purpose: Our aim was to explore whether maintenance of remission in patients with idiopathic inflammatory myopathy (IIM) depends on glucocorticoids (GCs) after achieving remission. Therefor…
  • Abstract Number: 1694 • ACR Convergence 2023

    Transcriptomic Analysis of the Impact of Iberdomide on Patients with SLE

    Prathyusha Bachali1, Shimon Korish2, Yanhua Hu3, Peter Schafer4, Amrie Grammer1 and Peter Lipsky1, 1AMPEL BioSolutions, Charlottesville, VA, 2Bristol Myers Squibb, Summit, NJ, 3Bristol Myers Squibb, Princeton, NJ, 4Bristol Myers Squibb, Belle Mead, NJ

    Background/Purpose: Iberdomide is a high affinity cereblon ligand that promotes ubiquitylation and proteasomal degradation of Ikaros (IKZF1) and Aiolos (IKZF3) transcription factors and, thereby altering…
  • Abstract Number: 1196 • ACR Convergence 2023

    Association of Long-Term Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) with Worsening Symptoms and Structural Changes of Knee Osteoarthritis: An Individual Patient Data Meta-Analysis of Cohort Studies

    Zubeyir Salis1 and Amanda Sainsbury2, 1The University of New South Wales, Kensington, Australia, 2The University of Western Australia, Crawley, Australia

    Background/Purpose: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are commonly prescribed for short-term management of symptoms of knee osteoarthritis (KOA), but they are often used long-term, and the…
  • Abstract Number: 1959 • ACR Convergence 2023

    Quantitative Scoring of High Resolution Chest Computed Tomography (HRCT) Images in Myositis and Antisynthetase Syndrome Related Interstitial Lung Disease in Comparison to Scleroderma Related Interstitial Lung Disease

    Sangmee Bae1, Fereidoun Abtin2, Grace Kim3, Siamak Moghadam-Kia4, Chester V. Oddis5, Lila Pourzand2, Didem Saygin5, Daniel Sullivan6, Koichi Yamaguchi7, Donald Tashkin3, Christina Charles-Schoeman8, Jonathan Goldin3 and Rohit Aggarwal5, 1UCLA Rheumatology, Los Angeles, CA, 2UCLA Radiological Sciences, Los Angeles, CA, 3University of California Los Angeles, Los Angeles, CA, 4University of Pittsburgh Medical Center, Pittsburgh, PA, 5University of Pittsburgh, Pittsburgh, PA, 6UCLA Pulmonology, Pittsburgh, PA, 7University of Pittsburgh Medical Center Rheumatology, Pittsburgh, PA, 8UCLA Medical Center, Santa Monica, CA

    Background/Purpose: High resolution computed tomography (HRCT) of the chest has become an important modality in the evaluation of interstitial lung disease (ILD). A quantitative CT…
  • Abstract Number: 1184 • ACR Convergence 2023

    A Wearable-Sensor for Assessment of Gait and Chair Stand Patterns in People with Knee Osteoarthritis: Validation and Responsiveness to Treatment of a Potential Digital Biomarker

    Deepak Kumar1, Lukas Adamowicz2, Benjamin Senderling1, Mary Gheller1, Michael LaValley3, Kathryn Bacon1, Pirinka Georgiev2, Charmaine Demanuele2, Paul Wacnik2 and Tuhina Neogi4, 1Boston University, Boston, MA, 2Pfizer Inc., Cambridge, MA, 3Boston University School of Public Health, Arlington, MA, 4Boston University School of Medicine, Boston, MA

    Background/Purpose: The objectives of this study in people with knee osteoarthritis (OA) were to (a) examine the agreement between measures of gait and chair stand…
  • Abstract Number: 1206 • ACR Convergence 2023

    Self-Perceptions of Aging and Physical Activity in Older Adults with Arthritis: Does General Health Matter?

    Sarah Lieber1, Jerad Moxley2, Lisa Mandl1, M. Carrington Reid2 and Sara Czaja2, 1Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 2Weill Cornell Medicine, New York, NY

    Background/Purpose: Negative self-perceptions of aging are generally associated with decreased physical function in older adults. Whether self-perceptions of aging (i.e., "awareness of age-related change" including…
  • Abstract Number: 1703 • ACR Convergence 2023

    Increased Mortality and Cardiovascular Events in Male Patients with Systemic Sclerosis: Left Ventricular Global Longitudinal Strain as Possible Screening Tool

    Jeska de Vries-Bouwstra1, Tea Gegenava2, Federico Fortuni3, Nina Van Leeuwen4, Anders Tennoe5, Anna Maria Hoffmann-Vold6, Ruxandra Jurcut7, Adrian Giuca7, Laura Groseanu8, Felix Tanner9, Oliver Distler10, Jeroen Bax11 and Nina Ajmone Marsan11, 1Leiden University Medical Center, Leiden, Netherlands, 2Department of Cardiology, Heart Lung Centre, Leiden University Medical Centre; Department of Internal Medicine,Tbilisi State Medical University, Tbilisi, Georgia, 3Department of Cardiology, San Giovanni Battista Hospital, Foligno, Italy, 4Department of Rheumatology, Leiden University Medical Centre, Leiden, Netherlands, 5Department of Rheumatology, Oslo University Hospital, Oslo, Norway, 6Oslo University Hospital, Department of Rheumatology, Oslo, Norway, 7Department of Cardiology, Emergency Institute for Cardiovascular Diseases “Prof .Dr. C. C. Iliescu”, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania, 8University of Medicine and Pharmacy "Carol Davila", Department of Internal Medicine -Rheumatology; Santa Maria Clinical Hospital, Internal Medicine and Rheumatology, Bucharest, Romania, 9Department of Cardiology, University Heart Centre, University Hospital Zurich, Zurich, Switzerland, 10Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 11Department of Cardiology, Heart Lung Centre, Leiden University Medical Centre, Leiden, Netherlands

    Background/Purpose: Systemic sclerosis (SSc) is less frequent in males, but the risk of severe outcomes is higher in males than in females(1). Seven to 30%…
  • Abstract Number: 1961 • ACR Convergence 2023

    Anti-PM/Scl Autoantibodies in Juvenile Myositis Are Associated with a Distinct Phenotype Resembling Anti-synthetase Syndrome

    Matthew Sherman1, Payam Noroozi Farhad2, Edward Trieu3, Katherine Pak4, Iago Pinal-Fernandez4, Kakali Sarkar2, Megan Neely5, Ira Targoff6, Frederick Miller7, Andrew Mammen8 and Lisa Rider9, 1NIAMS/NIH, Washington, DC, 2Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, 3Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4National Institutes of Health, Bethesda, MD, 5Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, 6Veterans Affairs Medical Center, University of Oklahoma Health Sciences Center, and Oklahoma Medical Research Foundation, Oklahoma City, OK, 7NIH, NIEHS, Chapel Hill, NC, 8NIH, Bethesda, MD, 9NIEHS, NIH, Bethesda, MD

    Background/Purpose: Anti-PM/Scl autoantibodies (Abs) are an uncommon myositis-associated autoantibody (MAA) in juvenile myositis. The clinical features and outcomes associated with anti-PM/Scl Abs in juvenile myositis…
  • « Previous Page
  • 1
  • …
  • 295
  • 296
  • 297
  • 298
  • 299
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology